Home » Newsletters » BioWorld MedTech

BioWorld MedTech

March 31, 2014

View Archived Issues

Exact Sciences gains unanimous FDA panel vote for Cologuard

Washington Roundup: March 26 the effective date for FDA's IIE notification process

Deals Roundup: Hardy Diagnostics becomes an employee-owned company

Agreements/Contracts: CryoLife acquires rights for ProCol from Hancock Labs

HIT Roundup: 3Pound launches Euco platform for patient-clinician engagement

Abbott's Supera given FDA approval for PAD treatment

Product briefs

People in Places

Briefly Noted

MDD's Neurology Extra

International report: Accuray's CyberKnife M6 receives Shonin approval

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
Gene replacement rescues autism-related phenotypes in mice
BioWorld Science
Autism spectrum disorder (ASD), developmental epileptic encephalopathies and other neurodevelopmental disorders are driven by the disruption of genes regulating...
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...